Paid Clinical Trials in Virginia

Virginia has 1,910 paid clinical trials enrolling now across cities including Richmond, Charlottesville and Fairfax. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Virginia include University of Virginia Health, VCU Health and Inova Health, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 14, 2026.

Filter results

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

1,735 clinical trials

Get a weekly email when new trials open in Richmond, VA.

Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

for Cancer

Sites in Fairfax +4 more locations

Sponsor: Conjupro Biotherapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07424547·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

for Idiopathic Pulmonary Fibrosis

Sites in Richmond, Falls Church +8 more locations

Sponsor: AbbVie

Sex: All·Age: 40+

Code: NCT07230288·Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer

for Ovarian Cancer

Drug: Bevacizumab

Sites in Fairfax +4 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT07278336·Phase 1·Recruiting·Listed Dec 2025

Apply to this trial

Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis

for Non-infectious Anterior Uveitis

Sites in Norfolk +5 more locations

Sponsor: Novaliq GmbH

Sex: All·Age: 18+

Code: NCT07285070·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

A Study of BI 3810944 in Patients With Advanced Cancer

for Solid Tumours

Sites in Charlottesville +3 more locations

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT07224425·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors

for Colorectal Cancer

Sites in Fairfax +4 more locations

Sponsor: PAQ Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07300150·Phase 1·Recruiting·Listed Dec 2025

Apply to this trial

A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

for Diabetes Mellitus, Type 1

Drug: Baricitinib

Sites in Charlottesville +6 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 1 - 35

Code: NCT07222137·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

for Diabetes Mellitus, Type 1

Drug: Baricitinib

Sites in Charlottesville +4 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 1 - 35

Code: NCT07222332·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours

for Locally Advanced Solid Tumor

Sites in Fairfax +5 more locations

Sponsor: Ipsen

Sex: All·Age: 18+

Code: NCT07213817·Phase 1, Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

for Sickle Cell Disease

Drug: Anumigilimab

Sites in Richmond +8 more locations

Sponsor: CSL Behring

Sex: All·Age: 18+

Code: NCT07224360·Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

for Head and Neck Squamous Cell Carcinoma HNSCC

Sites in Fairfax +8 more locations

Sponsor: Sutro Biopharma, Inc.

Sex: All·Age: 18+

Code: NCT07227168·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.

for Ankle Arthrodesis or Arthroplasty

Sites in Falls Church +6 more locations

Sponsor: Kuros Biosurgery AG

Sex: All·Age: 18 - 75

Code: NCT07225751·Recruiting·Listed Nov 2025

Apply to this trial

A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer

for Platinum-resistant Ovarian Cancer

Sites in Fairfax +6 more locations

Sponsor: Stemline Therapeutics, Inc.

Sex: Female·Age: 18+

Code: NCT07226427·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

for Non-small Cell Lung Cancer (NSCLC)

Sites in Fairfax +9 more locations

Sponsor: Astellas Pharma Global Development, Inc.

Sex: All·Age: 18+

Code: NCT07140016·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)

for Neoplasm Malignant

Drug: Calderasib

Sites in Fairfax +5 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT07209111·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)

for Lung Neoplasm Malignant

Sites in Fairfax +8 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06788912·Phase 2·Recruiting·Listed Jan 2025

Apply to this trial

A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)

for Muscular Atrophy, Spinal

Sites in Norfolk +2 more locations

Sponsor: Biogen

Sex: All·Age: 0 Days - 42 Days

Code: NCT07221669·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors

for Advanced Stage Solid Tumors

Sites in Fairfax +3 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT07107230·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

for Breast Neoplasms

Sites in Norfolk +7 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06797635·Phase 2·Recruiting·Listed Jan 2025

Apply to this trial

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

for Cancer

Sites in Fairfax +6 more locations

Sponsor: Angiex, Inc.

Sex: All·Age: 18+

Code: NCT06440005·Phase 1·Recruiting·Listed Jun 2024

Apply to this trial

First-in-Human Trial of VBC101 in Participants With Advanced Solid Tumor Malignancies

for Participants With Advanced Solid Tumor Malignancies

Sites in Fairfax +4 more locations

Sponsor: VelaVigo Bio Inc

Sex: All·Age: 18+

Code: NCT07136779·Phase 1, Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

for Advanced Solid Tumors

Sites in Richmond +6 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06818643·Phase 1, Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations

for Non-Small Cell Lung Cancer

Sites in Fairfax +8 more locations

Sponsor: Pierre Fabre Medicament

Sex: All·Age: 18+

Code: NCT06043817·Phase 1, Phase 2·Recruiting·Listed Sep 2023

Apply to this trial

COPD Exacerbation Follow Up

for COPD (Chronic Obstructive Pulmonary Disease)

Sites in Falls Church +4 more locations

Sponsor: Viz.ai, Inc.

Sex: All·Age: 40+

Code: NCT07118306·Recruiting·Listed Aug 2025

Apply to this trial

A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease

for Von Willebrand Disease, Type 3

Sites in Richmond +5 more locations

Sponsor: Hoffmann-La Roche

Sex: All·Age: 1 Month+

Code: NCT06998524·Phase 3·Recruiting·Listed May 2025

Apply to this trial

A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Fairfax +3 more locations

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT05765851·Phase 1·Recruiting·Listed Mar 2023

Apply to this trial

Study of GS-5319 Given Alone or in Combination in Adults With Solid Tumors

for Advanced Solid Tumor

Sites in Fairfax +3 more locations

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT07128303·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

for Advanced Solid Tumors

Sites in Fairfax +8 more locations

Sponsor: Accent Therapeutics

Sex: All·Age: 18+

Code: NCT06799065·Phase 1·Recruiting·Listed Jan 2025

Apply to this trial

A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

for Metastatic Castration-resistant Prostate Cancer

Sites in Fairfax +8 more locations

Sponsor: Daiichi Sankyo

Sex: Male·Age: 18+

Code: NCT07244341·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

for Esophageal Squamous Cell Carcinoma

Sites in Fairfax +12 more locations

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT06644781·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort

for Duchenne Muscular Dystrophy

Sites in Norfolk +10 more locations

Sponsor: Sarepta Therapeutics, Inc.

Sex: Male·Age: 2+

Code: NCT04626674·Phase 1·Recruiting·Listed Nov 2020

Apply to this trial

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

for Solid Tumor

Sites in Fairfax +9 more locations

Sponsor: STORM Therapeutics LTD

Sex: All·Age: 18+

Code: NCT06975293·Phase 1, Phase 2·Recruiting·Listed May 2025

Apply to this trial

A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)

for Congenital Adrenal Hyperplasia

Sites in Charlottesville +8 more locations

Sponsor: Crinetics Pharmaceuticals Inc.

Sex: All·Age: 1 - 17

Code: NCT07159841·Phase 2, Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

for Non-small Cell Lung Cancer

Sites in Fairfax +10 more locations

Sponsor: BioNTech SE

Sex: All·Age: 18+

Code: NCT07111520·Phase 1, Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

for Colorectal Cancer

Sites in Fairfax +12 more locations

Sponsor: Criterium, Inc.

Sex: All·Age: 18+

Code: NCT06992258·Phase 2·Recruiting·Listed May 2025

Apply to this trial

A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)

for Ovarian Cancer Recurrent

Sites in Charlottesville +8 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: Female·Age: 18+

Code: NCT06843447·Phase 1, Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)

for Duchenne Muscular Dystrophy

Sites in Norfolk +2 more locations

Sponsor: Solid Biosciences Inc.

Sex: Male·Age: 7 - 11

Code: NCT07160634·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL

for CTCL

Sites in Richmond +4 more locations

Sponsor: Prescient Therapeutics, Ltd.

Sex: All·Age: 18+

Code: NCT06854653·Phase 2·Recruiting·Listed Mar 2025

Apply to this trial

Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Fairfax +3 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT06598800·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

for Ovarian Cancer

Sites in Fairfax +19 more locations

Sponsor: Tubulis GmbH

Sex: All·Age: 18+

Code: NCT06303505·Phase 1, Phase 2·Recruiting·Listed Mar 2024

Apply to this trial